Kinetics of gene expression in murine cutaneous graft-versus-host disease

American Journal of Pathology

Volumn 164, Issue 6, 2004, Pages 2189-2202

  Sugerman, Philip B ^a   Faber, Sara B ^a   Willis, Lucy M ^b   Petrovic, Aleksandra ^b   Murphy, George F ^c   Pappo, Jacques ^a   Silberstein, David ^a   Van Den Brink, Marcel R M ^b  

^a ASTRAZENECA   (United Kingdom)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; B7 ANTIGEN; CASPASE 7; CD18 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; GRANZYME B; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1BETA; KERATIN; KERATIN 5; KERATIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METALLOTHIONEIN I; PROTEIN BAK; PROTEIN BAK1; PROTEIN BAX; PROTEIN BCL 2; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; SERUM AMYLOID A; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DISEASE COURSE; EFFECTOR CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; LYMPHOCYTIC INFILTRATION; MAST CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 2442646641     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63776-5     Document Type: Article

References (92)

1. Ferrara JL, Deeg HJ: Graft-versus-host disease. N Engl J Med 1991, 324:667-674
2. Korngold B, Sprent J: Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med 1978, 148:1687-1698
3. Ferrara J, Guillen FJ, Sleckman B, Burakoff SJ, Murphy GF: Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease. J Invest Dermatol 1986, 86:371-375
4. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte Jr J, Crawford JM, Ferrara JL: An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996, 88:3230-3239
5. Chudin E, Walker R, Kosaka A, Wu SX, Rabert D, Chang TK, Kreder DE: Assessment of the relationship between signal intensities and transcript concentration for Affymetrix GeneChip arrays. Genome Biol 2002, 3:RESEARCH0005
6. Murphy GF, Whitaker D, Sprent J, Korngold R: Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells. Am J Pathol 1991, 138:983-990
7. Gurish MF, Austen KF: The diverse roles of mast cells. J Exp Med 2001, 194:F1-F5
8. Denizot F, Brunet JF, Roustan P, Harper K, Suzan M, Luciani MF, Mattei MG, Golstein P: Novel structures CTLA-2 alpha and CTLA-2 beta expressed in mouse activated T cells and mast cells and homologous to cysteine proteinase proregions. Eur J Immunol 1989, 19:631-635
9. Holness CL, da Silva RP, Fawcett J, Gordon S, Simmons DL: Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/Igp family. J Biol Chem 1993, 268:9661-9666
10. Nagasawa R, Gross J, Kanagawa O, Townsend K, Lanier LL, Chiller J, Allison JP: Identification of a novel T cell surface disulfide-bonded dimer distinct from the alpha/beta antigen receptor. J Immunol 1987, 138:815-824
11. Yokoyama WM, Seaman WE: The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993, 11:613-635
12. Freeman GJ, Gray GS, Gimmi CD, Lombard DB, Zhou LJ, White M, Fingeroth JD, Gribben JG, Nadler LM: Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med 1991, 174:625-631
13. Gilliam AC, Murphy GF: Cellular pathology of cutaneous graft-versus-host disease. Graft-Versus-Host Disease, Ed 2, Revised and Expanded. Edited by JLM DH Ferrara, SJ Burakoff. New York, Marcel Dekker, Inc., 1997, pp 291-314
14. Gilliam AC, Whitaker-Menezes D, Korngold R, Murphy GF: Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease. J Invest Dermatol 1996, 107:377-383
15. Graubert TA, Russell JH, Ley TJ: The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 1996, 87:1232-1237
16. Mebius RE: Organogenesis of lymphoid tissues. Nat Rev Immunol 2003, 3:292-303
17. Creagh EM, Conroy H, Martin SJ: Caspase-activation pathways in apoptosis and immunity. Immunol Rev 2003, 193:10-21
18. Lippens S, VandenBroecke C, Van Damme E, Tschachler E, Vandenabeele P, Declercq W: Caspase-14 is expressed in the epidermis, the choroid plexus, the retinal pigment epithelium and thymic Hassall's bodies. Cell Death Differ 2003, 10:257-259
19. Opferman JT, Korsmeyer SJ: Apoptosis in the development and maintenance of the immune system. Nat Immunol 2003, 4:410-415
20. Ong ST, Hackbarth ML, Degenstein LC, Baunoch DA, Anastasi J, McKeithan TW: Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice. Oncogene 1998, 16:2333-2343
21. Cory S, Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002, 2:647-656
22. Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol 1997, 15:749-795
23. Boehm U, Guethlein L, Klamp T, Ozbek K, Schaub A, Futterer A, Pfeffer K, Howard JC: Two families of GTPases dominate the complex cellular response to IFN-gamma. J Immunol 1998, 161:6715-6723
24. Chu PG, Weiss LM: Keratin expression in human tissues and neoplasms. Histopathology 2002, 40:403-439
25. Mazzalupo S, Wong P, Martin P, Coulombe PA: Role for keratins 6 and 17 during wound closure in embryonic mouse skin. Dev Dyn 2003, 226:356-365
26. Steinert PM, Kartasova T, Marekov LN: Biochemical evidence that small proline-rich proteins and trichohyalin function in epithelia by modulation of the biomechanical properties of their cornified cell envelopes. J Biol Chem 1998, 273:11758-11769
27. Dinarello CA: Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998, 16:457-499
28. Attisano L, Wrana JL: Signal transduction by the TGF-beta superfamily. Science 2002, 296:1646-1647
29. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH: Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000, 1:119-126
30. Mitsui G, Mitsui K, Hirano T, Ohara O, Kato M, Niwano Y: Kinetic profiles of sequential gene expressions for chemokines in mice with contact hypersensitivity. Immunol Lett 2003, 86:191-197
31. Ichiba T, Teshima T, Kuick R, Misek DE, Liu C, Takada Y, Maeda Y, Reddy P, Williams DL, Hanash SM, Ferrara JL: Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood 2003, 102:763-771
32. Baker KS, Allen RD, Roths JB, Sidman CL: Kinetic and organ-specific patterns of cytokine expression in acute graft-versus-host disease. Bone Marrow Transplant 1995, 15:595-603
33. Hill GR, Cooke KR, Teshima T, Crawford JM, Keith Jr JC, Brinson YS, Bungard D, Ferrara JL: Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J Clin Invest 1998, 102:115-123
34. Sykes M, Szot GL, Nguyen PL, Pearson DA: Interleukin-12 inhibits murine graft-versus-host disease. Blood 1995, 86:2429-2438
35. Hu HZ, Li GL, Lim YK, Chan SH, Yap EH: Kinetics of interferon-gamma secretion and its regulatory factors in the early phase of acute graft-versus-host disease. Immunology 1999, 98:379-385
36. Zhang Y, McCormick LL, Desai SR, Wu C, Gilliam AC: Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 2002, 168:3088-3098
37. New JY, Li B, Koh WP, Ng HK, Tan SY, Yap EH, Chan SH, Hu HZ: T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease. Bone Marrow Transplant 2002, 29:979-986
38. Murphy GF, Sueki H, Teuscher C, Whitaker D, Korngold R: Role of mast cells in early epithelial target cell injury in experimental acute graft-versus-host disease. J Invest Dermatol 1994, 102:451-461
39. Christofidou-Solomidou M, Murphy GF, Albelda SM: Induction of E-selectin-dependent leukocyte recruitment by mast cell degranulation in human skin grafts transplanted on SCID mice. Am J Pathol 1996, 148:177-188
40. Klein LM, Lavker RM, Matis WL, Murphy GF: Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc Natl Acad Sci USA 1989, 86:8972-8976
41. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF: Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991, 88:4220-4224
42. Whitaker-Menezes D, Schechter NM, Murphy GF: Serine proteinases are regionally segregated within mast cell granules. Lab Invest 1995, 72:34-41
43. Kaminer MS, Lavker RM, Walsh LJ, Whitaker D, Zweiman B, Murphy GF: Extracellular localization of human connective tissue mast cell granule contents. J Invest Dermatol 1991, 96:857-863
44. Proudfoot AE: Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2002, 2:106-115
45. Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242
46. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, Dayer JM: CCR5 is characteristic of Th1 lymphocytes. Nature 1998, 391:344-345
47. Koga S, Auerbach MB, Engeman TM, Novick AC, Toma H, Fairchild RL: T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig. J Immunol 1999, 163:4878-4885
48. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA: Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003, 170:3233-3242
49. Pratt JR, Basheer SA, Sacks SH: Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002, 8:582-587
50. Larson RS, Springer TA: Structure and function of leukocyte integrins. Immunol Rev 1990, 114:181-217
51. Wagner N, Lohler J, Kunkel EJ, Ley K, Leung E, Krissansen G, Rajewsky K, Muller W: Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature 1996, 382:366-370
52. Huleatt JW, Lefrancois L: Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo. J Immunol 1995, 154:5684-5693
53. Yang J, Galipeau J, Kozak CA, Furie BC, Furie B: Mouse P-selectin glycoprotein ligand-1: molecular cloning, chromosomal localization, and expression of a functional P-selectin receptor. Blood 1996, 87:4176-4186
54. Borges E, Tietz W, Steegmaier M, Moll T, Hallmann R, Hamann A, Vestweber D: P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin. J Exp Med 1997, 185:573-578
55. Tovar V, de la Fuente MA, Pizcueta P, Bosch J, Engel P: Gene structure of the mouse leukocyte cell surface molecule Ly9. Immunogenetics 2000, 51:788-793
56. Sandrin MS, Gumley TP, Henning MM, Vaughan HA, Gonez LJ, Trapani JA, McKenzie IF: Isolation and characterization of cDNA clones for mouse Ly-9. J Immunol 1992, 149:1636-1641
57. Araki T, Zimonjic DB, Popescu NC, Milbrandt J: Mechanism of homophilic binding mediated by ninjurin, a novel widely expressed adhesion molecule. J Biol Chem 1997, 272:21373-21380
58. Moon AR, Oh GT, Kim JW, Choi YJ, Choe IS: Genomic DNA sequence and transcription factor binding sites of mouse ninjurin. DNA Seq 2001, 12:385-395
59. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301-314
60. Springer TA: Adhesion receptors of the immune system. Nature 1990, 346:425-434
61. Ebnet K, Kaldjian EP, Anderson AO, Shaw S: Orchestrated information transfer underlying leukocyte endothelial interactions. Annu Rev Immunol 1996, 14:155-177
62. Bierer BE, Peterson A, Barbosa J, Seed B, Burakoff SJ: Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation. Proc Natl Acad Sci USA 1988, 85:1194-1198
63. Gollob JA, Li J, Kawasaki H, Daley JF, Groves C, Reinherz EL, Ritz J: Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12. J Immunol 1996, 157:1886-1893
64. Chen CZ, Li M, de Graaf D, Monti S, Gottgens B, Sanchez MJ, Lander ES, Golub TR, Green AR, Lodish HF: Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc Natl Acad Sci USA 2002, 99:15468-15473
65. Jonker L, Arthur HM: Endoglin expression in early development is associated with vasculogenesis and angiogenesis. Mech Dev 2002, 110:193-196
66. Schlegel PG, Vaysburd M, Chen Y, Butcher EC, Chao NJ: Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers. J Immunol 1995, 155:3856-3865
67. Li B, New JY, Yap EH, Lu J, Chan SH, Hu H: Blocking L-selectin and alpha4-integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease. Eur J Immunol 2001, 31:617-624
68. Kim JC, Whitaker-Menezes D, Deguchi M, Adair BS, Korngold R, Murphy GF: Novel expression of vascular cell adhesion molecule-1 (CD106) by squamous epithelium in experimental acute graft-versus-host disease. Am J Pathol 2002, 161:763-770
69. Norton J, Sloane JP: ICAM-1 expression on epidermal keratinocytes in cutaneous graft-versus-host disease. Transplantation 1991, 51:1203-1206
70. Howell CD, Li J, Chen W: Role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 during nonsuppurative destructive cholangitis in a mouse graft-versus-host disease model. Hepatology 1999, 29:766-776
71. Masui T, Wakefield LM, Lechner JF, LaVeck MA, Sporn MB, Harris CC: Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci USA 1986, 83:2438-2442
72. Wei L, Debets R, Hegmans JJ, Benner R, Prens EP: IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production. J Pathol 1999, 187:358-364
73. Lange A, Klimczak A, Karabon L, Suchnicki K: Cytokines, adhesion molecules (E-selectin and VCAM-1) and graft-versus-host disease. Arch Immunol Ther Exp (Warsz) 1995, 43:99-105
74. Davidson WF, Calkins C, Hugins A, Giese T, Holmes KL: Cytokine secretion by C3H-Ipr and -gld T cells. Hypersecretion of IFN-gamma and tumor necrosis factor-alpha by stimulated CD4+ T cells. J Immunol 1991, 146:4138-4148
75. Gordon JR, Galli SJ: Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J Exp Med 1994, 180:2027-2037
76. Kendall JC, Li XH, Galli SJ, Gordon JR: Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: role for mast cell tumor necrosis factor-alpha and transforming growth factor-beta 1. J Allergy Clin Immunol 1997, 99:113-123
77. Vesey DA, Cheung C, Cuttle L, Endre Z, Gobe G, Johnson DW: Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism. J Lab Clin Med 2002, 140:342-350
78. Korngold R, Sprent J: Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex. Immunol Rev 1983, 71:5-29
79. Guillen FJ, Ferrara J, Hancock WW, Messadi D, Fonferko E, Burakoff SJ, Murphy GF: Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response. Lab Invest 1986, 55:35-42
80. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL: Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000, 12:721-727
81. Cerwenka A, O'Callaghan CA, Hamerman JA, Yadav R, Ajayi W, Roopenian DC, Joyce S, Lanier LL: Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D. J Immunol 2002, 168:3131-3134
82. Ferrara JL, Guillen FJ, van Dijken PJ, Marion A, Murphy GF, Burakoff SJ: Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease. Transplantation 1989, 47:50-54
83. van den Brink MR, Moore E, Horndasch KJ, Crawford JM, Hoffman J, Murphy GF, Burakoff SJ: Fas-deficient Ipr mice are more susceptible to graft-versus-host disease. J Immunol 2000, 164:469-480
84. Larson MA, Wei SH, Weber A, Weber AT, McDonald TL: Induction of human mammary-associated serum amyloid A3 expression by prolactin or lipopolysaccharide. Biochem Biophys Res Commun 2003, 301:1030-1037
85. Huang JH, Liao WS: Synergistic induction of mouse serum amyloid A3 promoter by the inflammatory mediators IL-1 and IL-6. J Interferon Cytokine Res 1999, 19:1403-1411
86. Su SB, Gong W, Gao JL, Shen W, Murphy PM, Oppenheim JJ, Wang JM: A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 1999, 189:395-402
87. Sodin-Semrl S, Taddeo B, Tseng D, Varga J, Fiore S: Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol 2000, 164:2660-2666
88. Aliberti J, Serhan C, Sher A: Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J Exp Med 2002, 196:1253-1262
89. Gewirtz AT, Collier-Hyams LS, Young AN, Kucharzik T, Guilford WJ, Parkinson JF, Williams IR, Neish AS, Madara JL: Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J Immunol 2002, 168:5260-5267
90. Jozsef L, Zouki C, Petasis NA, Serhan CN, Filep JG: Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc Natl Acad Sci USA 2002, 99:13266-13271
91. Ellison CA, Fischer JM, HayGlass KT, Gartner JG: Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors. Immunol 1998, 161:631-640
92. Murphy WJ, Welniak LA, Taub DD, Wiltrout RH, Taylor PA, Vallera DA, Kopf M, Young H, Longo DL, Blazar BR: Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest 1998, 102:1742-1748